市場調査レポート

米国の人工心臓弁市場:2016年 (2022年までの予測)

US Market for Heart Valve Devices - 2016 (Forecasted to 2022)

発行 iData Research Inc. 商品コード 146785
出版日 ページ情報 英文 134 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。

ご注意: Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の人工心臓弁市場:2016年 (2022年までの予測) US Market for Heart Valve Devices - 2016 (Forecasted to 2022)
出版日: 2015年09月01日 ページ情報: 英文 134 Pages
概要

米国の人工心臓弁 (心臓弁装置) 市場では近年、三尖弁の修復手術の件数が増加し、2015年には1万件以上に達しています。かつては「大動脈弁や僧帽弁を治療すれば、三尖弁逆流は治癒できる」と考えられ、三尖弁の手術は盛んに行われてきませんでしたが、三尖弁逆流を放置することの危険性を心臓医も認識し始めたため、治療手術が近年増加することとなりました。ただし、三尖弁逆流による死亡率は低いため、三尖弁の置換手術は現在も多くはありません。他方、米国における経カテーテル心臓弁手術の大半は、現在でもTAVI (経カテーテル大動脈弁移植) 装置が大半を占めています。FDA (米国食品医薬品局) による積極的な認可の動きも、TAVI装置の利用増加の一因となっています。

当レポートでは、米国の心臓手術装置 (人工心臓弁) 市場について分析し、製品別市場の概要と競合動向などについてまとめています。

目次

図表一覧

エグゼクティブ・サマリー

分析手法

  • 分析範囲
  • IDATAの9段階の分析手法

生体弁市場

  • イントロダクション
  • 処置件数
    • 心臓弁の種類別
    • 装置の種類別
    • 組織の種類別
  • 市場概要
  • 市場の分析と予測
    • 全体的な市場規模
    • 装置の種類別の市場
    • ステント付き心臓弁の市場
    • ステント無し心臓弁の市場
    • 無縫合心臓弁の市場
    • 組織の種類別の市場
    • 異種移植片の市場
    • 同種移植片の市場
  • 市場促進・抑制要因
  • 競合分析

機械弁市場

  • イントロダクション
  • 処置件数
    • 心臓弁の種類別
  • 市場概要
  • 市場の分析と予測
    • 全体的な市場規模
    • 導管無し機械弁の市場
    • 導管付き機械弁の市場
  • 市場促進・抑制要因
  • 競合分析

弁輪形成装置市場

  • イントロダクション
  • 処置件数
    • 心臓弁の種類別
    • 組織の種類別
  • 市場概要
  • 市場の分析と予測
    • 全体的な市場規模
    • リング装置市場
    • バンド装置市場
  • 市場促進・抑制要因
  • 競合分析
    • 大手企業
    • 将来性のある企業

経カテーテル心臓弁修復装置

  • イントロダクション
  • 処置件数
  • 市場の分析と予測
  • 市場促進・抑制要因
  • 競合分析
    • 大手企業
    • 将来性のある企業

経カテーテル心臓弁置換市場

  • イントロダクション
  • 処置件数
  • 市場の分析と予測
    • 経カテーテル大動脈弁置換市場
    • 新規市場
    • 経カテーテル僧帽弁置換市場
    • 経カテーテル肺動脈弁置換市場
  • 市場促進・抑制要因
  • 競合分析
    • 大手企業
    • 将来性のある企業

略語一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: iDATA_USHV16_RPT

In the past, it was assumed that correcting aortic or mitral valve disease would reduce tricuspid regurgitation. This assumption has historically kept the volume of tricuspid repair and replacement procedures relatively low. While the volume of tricuspid replacement procedures has remained low in recent years, the volume of tricuspid repair procedures has increased strongly, reaching over 10,000 procedures in 2015. The increase in tricuspid repair procedures has been pushed by a growing awareness among cardiologists of the hazards of leaving severe tricuspid regurgitation untreated. The volume of tricuspid replacement procedures has remained low due to the lower mortality rates associated with tricuspid repair relative to replacement.

The U.S. market for transcatheter heart valve devices comprises transcatheter repair and implantation devices. Though the markets for transcatheter repair and implantation devices have both experienced rapid growth in recent years, as of 2015, the majority of the U.S. market for transcatheter heart valve devices is represented by transcatheter aortic valve implantation (TAVI) devices. Strong growth in the U.S. market for TAVI devices has been set in motion by FDA approvals expanding the indication for use of these devices.

In June 2015, the FDA approved Edwards Lifesciences' SAPIEN 3® Transcatheter Heart Valve (THV) and Medtronic's CoreValve Evolut R® System for treating patients who are at high risk for open-heart surgery. The wider range of patients able to receive treatment with TAVI devices has driven double-digit growth in unit sales in recent years. Medtronic's entry into the U.S. market for TAVI devices has also helped to power growth in the value of the market. Since receiving approval from the FDA for the CoreValve® in early 2014, Medtronic has rapidly gained share in the U.S. market for TAVI devices. Despite the growing popularity of the CoreValve®, Edwards' SAPIEN® valve continues to hold the largest share of the U.S. market for TAVI devices.

This Report includes Segments On:

  • Tissue Heart Valves
  • Mechanical Heart Valves
  • Annuloplasty Repair Device Market
  • Transcatheter Heart Valve Repair Devices
  • Transcatheter Heart Valve Implantations

This 134 Page Report Includes:

  • In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible
  • Executive Summary
  • Trend Analysis by Segment
  • Market Value Forecasts until 2022 and History Back to 2012
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

In the past, it was assumed that correcting aortic or mitral valve disease would reduce tricuspid regurgitation. This assumption has historically kept the volume of tricuspid repair and replacement procedures relatively low. While the volume of tricuspid replacement procedures has remained low in recent years, the volume of tricuspid repair procedures has increased strongly. The increase in tricuspid repair procedures has been pushed by a growing awareness among cardiologists of the hazards of leaving severe tricuspid regurgitation untreated. The volume of tricuspid replacement procedures has remained low due to the lower mortality rates associated with tricuspid repair relative to replacement.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 SURGICAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET
  • 1.2 TRANSCATHETER HEART VALVE DEVICES MARKET

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

TISSUE HEART VALVE MARKET

  • 3.1 INTRODUCTION
  • 3.2 PROCEDURE NUMBERS
    • 3.2.1 Tissue Valve Replacement Procedures by Valve Type
    • 3.2.2 Tissue Valve Replacement Procedures by Device Type
    • 3.2.3 Tissue Valve Replacement Procedures by Tissue Type
      • 3.3 MARKET OVERVIEW
      • 3.4 MARKET ANALYSIS AND FORECAST
    • 3.4.1 Total Tissue Heart Valve Market
    • 3.4.2 Tissue Heart Valve Market by Device Type
    • 3.4.2.1 Stented Tissue Heart Valve Market
    • 3.4.2.2 Stentless Tissue Heart Valve Market
    • 3.4.2.3 Sutureless Tissue Heart Valve Market
    • 3.4.3 Tissue Heart Valve Market by Tissue Type
    • 3.4.3.1 Xenograft Tissue Heart Valve Market
    • 3.4.3.2 Allograft Tissue Heart Valve Market
  • 3.5 DRIVERS AND LIMITERS
    • 3.5.1 Market Drivers
    • 3.5.2 Market Limiters
  • 3.6 COMPETITIVE ANALYSIS

MECHANICAL HEART VALVE MARKET

  • 4.1 INTRODUCTION
  • 4.2 PROCEDURES NUMBERS
    • 4.2.1 Mechanical Valve Replacement Procedures by Valve Type
    • 4.2.2 Mechanical Valve Replacement Procedures by Valve Type
  • 4.3 MARKET OVERVIEW
  • 4.4 MARKET ANALYSIS AND FORECAST
    • 4.4.1 Total Mechanical Heart Valve Market
    • 4.4.2 Mechanical Valve w/out Conduit Market
    • 4.4.3 Mechanical Valve w/ Conduit Market
  • 4.5 DRIVERS AND LIMITERS
    • 4.5.1 Market Drivers
    • 4.5.2 Market Limiters
  • 4.6 COMPETITIVE ANALYSIS

ANNULOPLASTY REPAIR DEVICE MARKET

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURE NUMBERS
    • 5.2.1 Annuloplasty Repair Procedures by Valve Type
    • 5.2.2 Annuloplasty Repair Procedures by Device Type
  • 5.3 MARKET OVERVIEW
  • 5.4 MARKET ANALYSIS AND FORECAST
    • 5.4.1 Total Annuloplasty Repair Device Market
    • 5.4.2 Ring Device Market
    • 5.4.3 Band Device Market
  • 5.5 DRIVERS AND LIMITERS
    • 5.5.1 Market Drivers
    • 5.5.2 Market Limiters
  • 5.6 COMPETITIVE ANALYSIS
    • 5.6.1 Leading Competitors
    • 5.6.2 Potential Competitors

TRANSCATHETER HEART VALVE REPAIR DEVICE MARKET

  • 6.1 INTRODUCTION
  • 6.2 PROCEDURE NUMBERS
    • 6.2.1 Transcatheter Heart Valve Repair Procedures
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Transcatheter Heart Valve Repair Device Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS
    • 6.5.1 Leading Competitors
    • 6.5.2 Potential Competitors

TRANSCATHETER HEART VALVE IMPLANTATION MARKET

  • 7.1 INTRODUCTION
  • 7.2 PROCEDURE NUMBERS
    • 7.2.1 Transcatheter Heart Valve Implantation Procedures
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Transcatheter Aortic Valve Implantation Market
    • 7.3.2 Emerging Markets
    • 7.3.2.1 Transcatheter Mitral Valve Implantation Market
    • 7.3.2.2 Transcatheter Pulmonary Valve Implantation Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE ANALYSIS
    • 7.5.1 Leading Competitors
    • 7.5.2 Potential Competitors
      • 7.5.2.1 Transcatheter Aortic Valve Implantation Market
      • 7.5.2.2 Transcatheter Mitral Valve Implantation Market
      • 7.5.2.3 Transcatheter Pulmonary Valve Implantation Market

ABBREVIATIONS 115

Back to Top